NNZ-2566: A Gly–Pro–Glu analogue with neuroprotective efficacy in a rat model of acute focal stroke
@article{Bickerdike2009NNZ2566AG, title={NNZ-2566: A Gly–Pro–Glu analogue with neuroprotective efficacy in a rat model of acute focal stroke}, author={M. J. Bickerdike and G. Thomas and D. C. Batchelor and E. Sirimanne and P. Gluckman}, journal={Journal of the Neurological Sciences}, year={2009}, volume={278}, pages={85-90} }
The N-terminal cleavage product of human insulin-like growth factor-1 (IGF-1) in the brain is the tripeptide molecule Glypromate (Gly-Pro-Glu). Glypromate has demonstrated neuroprotective effects in numerous in vitro and in vivo models of brain injury and is in clinical trials for the prevention of cognitive impairment following cardiac surgery. NNZ-2566 is a structural analogue of Glypromate, resulting from alpha-methylation of the proline moiety, which has improved the elimination half-life… Expand
23 Citations
GPE and GPE analogues as promising neuroprotective agents.
- Chemistry, Medicine
- Mini reviews in medicinal chemistry
- 2012
- 24
The role for IGF-1-derived small neuropeptides as a therapeutic target for neurological disorders
- Medicine
- Expert opinion on therapeutic targets
- 2015
- 20
Neuroprotection with Glycine-2-Methylproline-Glutamate (G-2MePE) after hypoxic-ischemic brain injury in adult rats
- Medicine
- 2014
- PDF
NNZ-2566, a Glypromate Analog, Attenuates Brain Ischemia-Induced Non-Convulsive Seizures in Rats
- Medicine
- Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
- 2009
- 21
- Highly Influenced
- PDF
Mechanism of Action for NNZ-2566 Anti-inflammatory Effects Following PBBI Involves Upregulation of Immunomodulator ATF3
- Biology, Medicine
- NeuroMolecular Medicine
- 2013
- 19
- PDF
IGF‐1 derived small neuropeptides and analogues: a novel strategy for the development of pharmaceuticals for neurological conditions
- Medicine
- British journal of pharmacology
- 2009
- 41
NNZ-2566, a Novel Analog of (1–3) IGF-1, as a Potential Therapeutic Agent for Fragile X Syndrome
- Psychology, Medicine
- NeuroMolecular Medicine
- 2015
- 41
- PDF
Insulin‐Like Growth Factor ‐1 (IGF‐1) Derived Neuropeptides, a Novel Strategy for the Development of Pharmaceuticals for Managing Ischemic Brain Injury
- Medicine
- CNS neuroscience & therapeutics
- 2011
- 12
Population pharmacokinetics of NNZ‐2566 in healthy subjects
- Medicine
- European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
- 2017
- 2
- Highly Influenced
- PDF
Cognitive enhancers (nootropics). Part 3: drugs interacting with targets other than receptors or enzymes. disease-modifying drugs.
- Medicine
- Journal of Alzheimer's disease : JAD
- 2013
- 14
- PDF
References
SHOWING 1-10 OF 36 REFERENCES
Neuroprotective effects of Gly-Pro-Glu, the N-terminal tripeptide of IGF-1, in the hippocampus in vitro.
- Biology, Medicine
- Neuroreport
- 1999
- 50
Neuroprotective effects of the N-terminal tripeptide of IGF-1, glycine-proline-glutamate, in the immature rat brain after hypoxic–ischemic injury
- Medicine
- Brain Research
- 2001
- 81
Neuroprotective effects of the N-terminal tripeptide of insulin-like growth factor-1, glycine-proline-glutamate (GPE) following intravenous infusion in hypoxic–ischemic adult rats
- Medicine
- Neuropharmacology
- 2004
- 63
Delayed Peripheral Administration of a GPE Analogue Induces Astrogliosis and Angiogenesis and Reduces Inflammation and Brain Injury following Hypoxia-Ischemia in the Neonatal Rat
- Medicine
- Developmental Neuroscience
- 2007
- 35
Pharmacokinetics of glycine-proline-glutamate, the N-terminal tripeptide of insulin-like growth factor-1, in rats.
- Chemistry, Medicine
- Analytical biochemistry
- 2003
- 32
Central penetration and stability of N-terminal tripeptide of insulin-like growth factor-I, glycine-proline-glutamate in adult rat
- Biology, Medicine
- Neuropeptides
- 2005
- 41
Identification of Gly-Pro-Glu (GPE), the aminoterminal tripeptide of insulin-like growth factor 1 which is truncated in brain, as a novel neuroactive peptide.
- Chemistry, Medicine
- Biochemical and biophysical research communications
- 1989
- 94
N-terminal tripeptide of IGF-1 (GPE) prevents the loss of TH positive neurons after 6-OHDA induced nigral lesion in rats
- Biology, Medicine
- Brain Research
- 2000
- 89
Delayed treatment with AM-36, a novel neuroprotective agent, reduces neuronal damage after endothelin-1-induced middle cerebral artery occlusion in conscious rats.
- Medicine
- Stroke
- 1999
- 66
Effects of IGF-1, truncated IGF-1 and the tripeptide Gly-Pro-Glu on acetylcholine release from parietal cortex of rat brain.
- Biology, Medicine
- Neuroreport
- 1993
- 36